# OnCo record paper-mountaineer-nat-commun-2026-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-mountaineer-nat-commun-2026-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-mountaineer-nat-commun-2026-update" ;
  schema:name "Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 +, RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis"@en ;
  schema:description "Later report from the MOUNTAINEER trial registered as NCT03043313, in Nature Communications (2026); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-mountaineer-nat-commun-2026-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41467-025-67824-z>, <https://pubmed.ncbi.nlm.nih.gov/41526345/>, <https://europepmc.org/article/MED/41526345>, <https://clinicaltrials.gov/study/NCT03043313> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1038/s41467-025-67824-z> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Strickler JH, Cercek A, Siena S, et al." ;
  onco:trials <https://onco.cc/trials/mountaineer/> ;
  onco:journals <https://onco.cc/journals/nature-communications/> .